A new team of internationally recognized experts will lead the expanded Bone Marrow Transplant and Cell Therapies Program at the George Washington University (GW) Cancer Center.
John Barrett, MD, professor of medicine at the GW School of Medicine and Health Sciences, is leading the expansion, including the translation of clinical research efforts into novel immune cell-based therapies. He is joined by Catherine Bollard, MD, associate center director for translational research and innovation at the GW Cancer Center, who is a pioneer in the field of immune cell therapies, in particular, novel T-cell based treatments for pediatric and adult patients with hematologic malignancies. The team also includes Eric Yvon, PhD, whom Bollard recruited to the GW Cancer Center from MD Anderson Cancer Center. Yvon has been appointed director of the newly established cGMP Cellular Production Facility at the GW Cancer Center.
